Skip to main content
. Author manuscript; available in PMC: 2014 Sep 9.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2

Analysis 1.33. Comparison 1 Mirtazapine versus TCAs, Outcome 33 Secondary outcome (SKEWED DATA: depression severity) at end of the acute-phase treatment.

Secondary outcome (SKEWED DATA: depression severity) at end of the acute-phase treatment

Study Comparator Measurement Mirtazapine: mean SD N Comparator: mean SD N Note
Hoyberg 1996 Amitripty-line HAMD-21 change score −11.1 7.9 54 −13.1 7.5 59
Marttila 1995 Doxepin HAMD-17 9.15 7.5 83 9.0 6.35 80
Mullin 1996 Amitripty-line HAMD-17 11.7 7.3 71 10.7 6.8 71
Zivkov 1995 Amitripty-line HAMD-21 12.8 10.1 113 12.0 10.0 111